John Timmerman

4PUBLICATIONS
50CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Aug 01, 2023
Axicabtagene Ciloleucel in Combination with the 4-1BB Agonist Utomilumab in Patients with Relapsed/Refractory Large B-Cell Lymphoma: Phase 1 Results from ZUMA-11.

Michael D Jain, David B Miklos, Caron A Jacobson

|Nov 23, 2022
CD19/CD20 Bispecific Chimeric Antigen Receptor (CAR) in Naive/Memory T Cells for the Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma.

Sarah M Larson, Christopher M Walthers, Brenda Ji

|Oct 19, 2022
Hypophosphatemia Due to Increased Effector Cell Metabolic Activity Is Associated with Neurotoxicity Symptoms in CD19-Targeted CAR T-cell Therapy.

Jack Pengfei Tang, Cole W Peters, Crystal Quiros

|Oct 26, 2020
Nivolumab Treatment of Burkitt Lymphoma: A Case Report.

B Scott Colton, Nicholas Hornstein, John Timmerman

Pageof 1

Frequent Collaborators

1 joint publications

Jack Pengfei Tang

1 joint publications

Cole W Peters

1 joint publications

Crystal Quiros

1 joint publications

Xiaoyan Wang